Exhaustive in silico design and screening of novel antipsychotic compounds with improved pharmacodynamics and blood-brain barrier permeation properties

References

• Adenot, M., & Lahana, R. (2004). Blood-brain barrier permeation models: Discriminating between potential CNS and Non-CNS drugs including P-glycoprotein substrates. Journal of Chemical Information and Computer Sciences, 44(1), 239–248. https://doi.org/10.1021/ci034205d
   PubMedGoogle Scholar
• Aga, V. M., Shad, M. U., Zhu, H., & Salzman, C. (2020). Psychopharmacologic treatment. Handbook of mental health and aging (pp. 315–399). Elsevier. ISBN 9780128001363.
   Google Scholar
• Andersen, K., Liljefors, T., Hyttel, J., & Perregaard, J. (1996). Serotonin 5-HT2 receptor, dopamine D2 receptor, and α1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole. Journal of Medicinal Chemistry, 39(19), 3723–3738. https://doi.org/10.1021/jm960159f
   PubMed Web of Science ®Google Scholar
• Arnt, J., & Skarsfeldt, T. (1998). Do novel antipsychotics have similar pharmacologial characteristics? A review of the evidence. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 18(2), 63–101. https://doi.org/10.1016/S0893-133X(97)00112-7
   PubMed Web of Science ®Google Scholar
• Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. https://doi.org/10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• Bai, Y., Chen, G., Yang, H., & Gao, K. (2020). Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics? Journal of Affective Disorders, 261, 259–270. https://doi.org/10.1016/j.jad.2019.10.012
   PubMed Web of Science ®Google Scholar
• Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263. https://doi.org/10.1093/nar/gky318
   PubMed Web of Science ®Google Scholar
• Barnes, T. R. E., & Edwards, J. G. (1993). The side-effects of antipsychotic drugs. I. CNS and neuromuscular effects. Antipsychotic drugs and their side-effects (pp. 213–247). Academic Press.
   Google Scholar
• Benigni, R., & Bossa, C. (2011). Mechanisms of chemical carcinogenicity and mutagenicity: A review with implications for predictive toxicology. Chemical Reviews, 111(4), 2507–2536. https://doi.org/10.1021/cr100222q
   PubMed Web of Science ®Google Scholar
• Berman, H. M. (2003). The protein data bank. Leadership in science and technology: A reference handbook (Vol 44, pp. 661–667). SAGE Publications, Inc.
   Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, IN., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Blagg, J. (2010). Structural alerts for toxicity. In D. J. Abraham (Ed.), Burger’s medicinal chemistry and drug discovery (pp. 301–334). John Wiley & Sons, Inc. ISBN 0471266949.
   Google Scholar
• Broccatelli, F., Carosati, E., Neri, A., Frosini, M., Goracci, L., Oprea, T. I., & Cruciani, G. (2011). A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. Journal of Medicinal Chemistry, 54(6), 1740–1751. https://doi.org/10.1021/jm101421d
   PubMed Web of Science ®Google Scholar
• Bruns, R. F., & Watson, I. A. (2012). Rules for identifying potentially reactive or promiscuous compounds. Journal of Medicinal Chemistry, 55(22), 9763–9772. https://doi.org/10.1021/jm301008n
   PubMed Web of Science ®Google Scholar
• Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G. V., Christie, C. H., Dalenberg, K., Di Costanzo, L., Duarte, J. M., Dutta, S., Feng, Z., Ganesan, S., Goodsell, D. S., Ghosh, S., Green, R. K., Guranović, V., Guzenko, D., Hudson, B. P., … Zhuravleva, M. (2021). RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Research, 49(D1), D437–D451. https://doi.org/10.1093/nar/gkaa1038
   PubMed Web of Science ®Google Scholar
• Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G. V., Duarte, J. M., Dutta, S., Fayazi, M., Feng, Z., Flatt, J. W., Ganesan, S. J., Goodsell, D. S., Ghosh, S., Kramer Green, R., Guranovic, V., Henry, J., Hudson, B. P., Lawson, C. L., … Zardecki, C. (2022). RCSB Protein Data Bank: Celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D. Protein Science: A Publication of the Protein Society, 31(1), 187–208. https://doi.org/10.1002/pro.4213
   PubMed Web of Science ®Google Scholar
• Burns, M. J. (2001). The pharmacology and toxicology of atypical antipsychotic agents. Journal of Toxicology. Clinical Toxicology, 39(1), 1–14. https://doi.org/10.1081/CLT-100102873
   PubMed Web of Science ®Google Scholar
• Cantù, F., Ciappolino, V., Enrico, P., Moltrasio, C., Delvecchio, G., & Brambilla, P. (2021). Augmentation with atypical antipsychotics for treatment-resistant depression. Journal of Affective Disorders, 280(Pt A), 45–53. https://doi.org/10.1016/j.jad.2020.11.006
   PubMedGoogle Scholar
• Chen, L., Li, Y., Zhao, Q., Peng, H., & Hou, T. (2011). ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and Naive Bayesian classification techniques. Molecular Pharmaceutics, 8(3), 889–900. https://doi.org/10.1021/mp100465q
   PubMed Web of Science ®Google Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/10.1021/ci300367a
   PubMed Web of Science ®Google Scholar
• Cheng, T., Zhao, Y., Li, X., Lin, F., Xu, Y., Zhang, X., Li, Y., Wang, R., & Lai, L. (2007). Computation of octanol-water partition coefficients by guiding an additive model with knowledge. Journal of Chemical Information and Modeling, 47(6), 2140–2148. https://doi.org/10.1021/ci700257y
   PubMed Web of Science ®Google Scholar
• Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Han, G. W., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., & Stevens, R. C. (2010). Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science (New York, N.Y.), 330(6007), 1091–1095. https://doi.org/10.1126/science.1197410
   PubMed Web of Science ®Google Scholar
• Clark, D. E. (1999). Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. Journal of Pharmaceutical Sciences, 88(8), 815–821. https://doi.org/10.1021/js980402t
   PubMed Web of Science ®Google Scholar
• Clarke, Z. (2007). Emonapride. In S. J. Enna & D. B. Bylund (Eds.), xPharm: The comprehensive pharmacology reference (pp. 1–3). Elsevier. ISBN 9780080552323.
   Google Scholar
• Cobaugh, D. J., Erdman, A. R., Booze, L. L., Scharman, E. J., Christianson, G., Manoguerra, A. S., Caravati, E. M., Chyka, P. A., Woolf, A. D., Nelson, L. S., & Troutman, W. G. (2007). Atypical antipsychotic medication poisoning: An evidence-based consensus guideline for out-of-hospital management. Clinical Toxicology (Philadelphia, PA.), 45(8), 918–942. https://doi.org/10.1080/15563650701665142
   PubMed Web of Science ®Google Scholar
• Cumming, J. G., Davis, A. M., Muresan, S., Haeberlein, M., & Chen, H. (2013). Chemical predictive modelling to improve compound quality. Nature Reviews. Drug Discovery, 12(12), 948–962. https://doi.org/10.1038/nrd4128
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology (Clifton, N.J.), 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
   PubMedGoogle Scholar
• Dalpiaz, A., Gessi, S., Borea, P. A., & Gilli, G. (1995). Binding thermodynamics of serotonin to rat-brain 5-HT1A, 5HT2A and 5-HT3 receptors. Life Sciences, 57(12), PL141–146.
   PubMed Web of Science ®Google Scholar
• de Bartolomeis, A., Barone, A., Begni, V., & Riva, M. A. (2022). Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacological Research, 176, 106078. https://doi.org/10.1016/J.PHRS.2022.106078
   PubMed Web of Science ®Google Scholar
• De las Cuevas, C., Sanz, E. J., Ruan, C. J., & de Leon, J. (2021). Clozapine-associated myocarditis in the World Health Organization’s pharmacovigilance database: Focus on reports from various countries. Revista de Psiquiatria y Salud Mental, 15(4), 238-250. https://doi.org/10.1016/j.rpsm.2021.07.004
   Web of Science ®Google Scholar
• De Leon, J. (2009). Pharmacogenomics: The promise of personalized medicine for CNS disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 34(1), 159–172. https://doi.org/10.1038/npp.2008.147
   PubMed Web of Science ®Google Scholar
• Deng, C., & Dean, B. (2013). Mapping the pathophysiology of schizophrenia: Interactions between multiple cellular pathways. Frontiers in Cellular Neuroscience, 7, 238. https://doi.org/10.3389/fncel.2013.00238
   PubMed Web of Science ®Google Scholar
• Durcan, M. J., Rigdon, G. C., Norman, M. H., & Morgan, P. F. (1995). Is clozapine selective for the dopamine D4 receptor? Life Sciences, 57(18), PL275–PL283. https://doi.org/10.1016/0024-3205(95)02151-8
   PubMed Web of Science ®Google Scholar
• Edwards, J. G., & Barnes, T. R. E. (1993). The side-effects of antipsychotic drugs. II. Effects on other physiological systems. Antipsychotic drugs and their side-effects (pp. 249–275). Academic Press.
   Google Scholar
• Edwards, S. J., & Smith, C. J. (2009). Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: A mixed treatment comparison of randomized controlled trials. Clinical Therapeutics. 31, 1345–1359. https://doi.org/10.1016/j.clinthera.2009.07.004
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. https://doi.org/10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• Enoch, S. J., Ellison, C. M., Schultz, T. W., & Cronin, M. T. D. (2011). A review of the electrophilic reaction chemistry involved in covalent protein binding relevant to toxicity. Critical Reviews in Toxicology, 41(9), 783–802. https://doi.org/10.3109/10408444.2011.598141
   PubMed Web of Science ®Google Scholar
• Ertl, P. (2021). Magic rings: Navigation in the ring chemical space guided by the bioactive rings. Journal of Chemical Information and Modeling, 62(9), 2164–2170. https://doi.org/10.1021/ACS.JCIM.1C00761/SUPPL_FILE/CI1C00761_SI_001.TXT
   PubMed Web of Science ®Google Scholar
• Ertl, P., Rohde, B., & Selzer, P. (2000). Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. Journal of Medicinal Chemistry, 43(20), 3714–3717. https://doi.org/10.1021/jm000942e
   PubMed Web of Science ®Google Scholar
• Eugene, A. R., Eugene, B., Masiak, M., & Masiak, J. S. (2021). Head-to-head comparison of sedation and somnolence among 37 antipsychotics in schizophrenia, bipolar disorder, major depression, autism spectrum disorders, delirium, and repurposed in COVID-19, infectious diseases, and oncology from the FAERS, 2004–2020. Frontiers in Pharmacology, 12, 295. https://doi.org/10.3389/fphar.2021.621691
   Web of Science ®Google Scholar
• Freedman, S. B., Patel, S., Marwood, R., Emms, F., Seabrook, G. R., Knowles, M. R., & McAllister, G. (1994). Expression and pharmacological characterization of the human D3 dopamine receptor. The Journal of Pharmacology and Experimental Therapeutics, 268(1), 417–426.
   PubMed Web of Science ®Google Scholar
• Ganapathiraju, M. K., Thahir, M., Handen, A., Sarkar, S. N., Sweet, R. A., Nimgaonkar, V. L., Loscher, C. E., Bauer, E. M., & Chaparala, S. (2016). Schizophrenia interactome with 504 novel protein-protein interactions. npj Schizophrenia. 2, 1–10. https://doi.org/10.1038/npjschz.2016.12
   PubMedGoogle Scholar
• Gehlhaar, D. K., Verkhivker, G., Rejto, P. A., Fogel, D. B., Fogel, L. J., & Freer, S. T. (1995). Docking conformationally flexible small molecules into a protein binding site through evolutionary programming. In J. R. McDonnell, R. G. Reynolds, & D. B. Fogel (Eds.), Evolutionary Programming IV: Proceedings of the Fourth Annual Conference on Evolutionary Programming (pp. 615–627).
   Google Scholar
• Gleeson, M. P. (2008). Generation of a set of simple, interpretable ADMET rules of thumb. Journal of Medicinal Chemistry, 51(4), 817–834. https://doi.org/10.1021/jm701122q
   PubMed Web of Science ®Google Scholar
• Haddad, C., Dib, J. E., Akl, N., Hallit, S., & Obeid, S. (2022). COVID-19 and psychosis, depression, obsession and quality of life in Lebanese patients with schizophrenia: Any changes after 5 months of quarantine? BMC Psychology, 10, 1–10. https://doi.org/10.1186/s40359-022-00750-7
   PubMedGoogle Scholar
• Hall, H., Köhler, C., & Gawell, L. (1985). Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain. European Journal of Pharmacology, 111(2), 191–199. https://doi.org/10.1016/0014-2999(85)90756-3
   PubMed Web of Science ®Google Scholar
• Hall, H., Sällemark, M., & Jerning, E. (1986). Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. Acta Pharmacologica et Toxicologica, 58(1), 61–70. https://doi.org/10.1111/j.1600-0773.1986.tb00071.x
   PubMedGoogle Scholar
• Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36. https://doi.org/10.1148/radiology.143.1.7063747
   PubMed Web of Science ®Google Scholar
• Harding, S. D., Armstrong, J. F., Faccenda, E., Southan, C., Alexander, S. P. H., Davenport, A. P., Pawson, A. J., Spedding, M., & Davies, J. A, NC-IUPHAR. (2022). The IUPHAR/BPS guide to PHARMACOLOGY in 2022: Curating pharmacology for COVID-19, malaria and antibacterials. Nucleic Acids Research, 50(D1), D1282–D1294. https://doi.org/10.1093/nar/gkab1010
   PubMed Web of Science ®Google Scholar
• Harel, S., & Radinsky, K. (2018). Prototype-based compound discovery using deep generative models. Molecular Pharmaceutics, 15(10), 4406–4416. https://doi.org/10.1021/acs.molpharmaceut.8b00474
   PubMed Web of Science ®Google Scholar
• Harris, A. (2020). A brief guide to medications for psychosis. A clinical introduction to psychosis (pp. 537–560). Elsevier. ISBN 9780128150122.
   Google Scholar
• Heron, P., Spanakis, P., Crosland, S., Johnston, G., Newbronner, E., Wadman, R., Walker, L., Gilbody, S., & Peckham, E. (2022). Loneliness among people with severe mental illness during the COVID-19 pandemic: Results from a linked UK population cohort study. PloS One, 17(1), e0262363. https://doi.org/10.1371/journal.pone.0262363
   PubMed Web of Science ®Google Scholar
• Horvath, D., Lisurek, M., Rupp, B., Kühne, R., Specker, E., von Kries, J., Rognan, D., Andersson, C. D., Almqvist, F., Elofsson, M., Enqvist, P.-A., Gustavsson, A.-L., Remez, N., Mestres, J., Marcou, G., Varnek, A., Hibert, M., Quintana, J., & Frank, R. (2014). Design of a general-purpose European compound screening library for EU-OPENSCREEN. ChemMedChem,.9(10), 2309–2326. https://doi.org/10.1002/cmdc.201402126
   PubMed Web of Science ®Google Scholar
• Hu, Y., Zhang, H., Wang, H., Wang, C., Kung, S., & Li, C. (2022). Adjunctive antidepressants for the acute treatment of bipolar depression: A systematic review and meta-analysis. Psychiatry Research, 311, 114468. https://doi.org/10.1016/j.psychres.2022.114468
   PubMed Web of Science ®Google Scholar
• Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., Decrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., Greene, N., Huang, E., Krieger-Burke, T., Loesel, J., Wager, T., Whiteley, L., & Zhang, Y. (2008). Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & Medicinal Chemistry Letters, 18(17), 4872–4875. https://doi.org/10.1016/j.bmcl.2008.07.071
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., & Shoichet, B. K. (2005). ZINC − A free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182. https://doi.org/10.1021/ci049714+
   PubMed Web of Science ®Google Scholar
• Jayaraj, J. M., Jothimani, M., Palanisamy, C. P., Pentikäinen, O. T., Pannipara, M., Al-Sehemi, A. G., Muthusamy, K., & Gopinath, K. (2022). Computational study on the inhibitory effect of natural compounds against the SARS-CoV-2 proteins. Bioinorganic Chemistry and Applications, 2022, 1–19. https://doi.org/10.1155/2022/8635054
   Web of Science ®Google Scholar
• Jeffrey, P., & Summerfield, S. (2010). Assessment of the blood–brain barrier in CNS drug discovery. Neurobiology of Disease, 37(1), 33–37. https://doi.org/10.1016/j.nbd.2009.07.033
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/10.1002/jcc.20945
   PubMed Web of Science ®Google Scholar
• Jongsma, H. E., Turner, C., Kirkbride, J. B., & Jones, P. B. (2019). International incidence of psychotic disorders, 2002–17: A systematic review and meta-analysis. The Lancet. Public Health, 4(5), e229–e244. https://doi.org/10.1016/S2468-2667(19)30056-8
   PubMed Web of Science ®Google Scholar
• Kim, D. H., & Stahl, S. M. (2010). Antipsychotic drug development. Current topics in behavioral neurosciences (Vol. 4, pp. 124–139). Springer. ISBN 9783642137167.
   Google Scholar
• Kimura, K. T., Asada, H., Inoue, A., Kadji, F. M. N., Im, D., Mori, C., Arakawa, T., Hirata, K., Nomura, Y., Nomura, N., Aoki, J., Iwata, S., & Shimamura, T. (2019). Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine. Nature Structural & Molecular Biology, 26(2), 121–128. https://doi.org/10.1038/s41594-018-0180-z
   PubMed Web of Science ®Google Scholar
• Kondej, M., Stępnicki, P., & Kaczor, A. A. (2018). Multi-target approach for drug discovery against schizophrenia. International Journal of Molecular Sciences. 19, 3105. https://doi.org/10.3390/ijms19103105
   PubMed Web of Science ®Google Scholar
• Kongsamut, S., Kang, J., Chen, X. L., Roehr, J., & Rampe, D. (2002). A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. European Journal of Pharmacology, 450(1), 37–41. https://doi.org/10.1016/S0014-2999(02)02074-5
   PubMed Web of Science ®Google Scholar
• Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003). HL-Histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 28(3), 519–526. https://doi.org/10.1038/sj.npp.1300027
   PubMed Web of Science ®Google Scholar
• Kučerka, N., Tristram-Nagle, S., & Nagle, J. F. (2005). Structure of fully hydrated fluid phase lipid bilayers with monounsaturated chains. The Journal of Membrane Biology, 208(3), 193–202. https://doi.org/10.1007/s00232-005-7006-8
   PubMed Web of Science ®Google Scholar
• Kunwittaya, S., Nantasenamat, C., Treeratanapiboon, L., Srisarin, A., Isarankura-Na-Ayudhya, C., & Prachayasittikul, V. (2013). Influence of logBB cut-off on the prediction of blood-brain barrier permeability. Biomedical and Applied Technology Journal, 1, 16–34.
   Google Scholar
• Lagorce, D., Bouslama, L., Becot, J., Miteva, M. A., & Villoutreix, B. O. (2017). FAF-Drugs4: Free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics (Oxford, England), 33(22), 3658–3660. https://doi.org/10.1093/bioinformatics/btx491
   PubMed Web of Science ®Google Scholar
• Lagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017). Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Scientific Reports, 7, 46277. https://doi.org/10.1038/srep46277
   PubMed Web of Science ®Google Scholar
• Lagorce, D., Sperandio, O., Baell, J. B., Miteva, M. A., & Villoutreix, B. O. (2015). FAF-Drugs3: A web server for compound property calculation and chemical library design. Nucleic Acids Research, 43(W1), W200–W207. https://doi.org/10.1093/nar/gkv353
   PubMed Web of Science ®Google Scholar
• Lahti, R. A., Evans, D. L., Stratman, N. C., & Figur, L. M. (1993). Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: Possible therapeutic implications. European Journal of Pharmacology, 236(3), 483–486. https://doi.org/10.1016/0014-2999(93)90488-4
   PubMed Web of Science ®Google Scholar
• Leo, A. J. (1993). Calculating log Poct from structures. Chemical Reviews, 93(4), 1281–1306. https://doi.org/10.1021/cr00020a001
   Web of Science ®Google Scholar
• Lesage, A. S., Wouters, R., Van Gompel, P., Heylen, L., Vanhoenacker, P., Haegeman, G., Luyten, W., & Leysen, J. E. (1998). Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT(1B) and 5-HT(1D) receptors expressed in various mammalian cell lines. British Journal of Pharmacology, 123(8), 1655–1665. https://doi.org/10.1038/sj.bjp.0701766
   PubMed Web of Science ®Google Scholar
• Leysen, J. E., Gommeren, W., Heylen, L., Luyten, W. H., Van de Weyer, I., Vanhoenacker, P., Haegeman, G., Schotte, A., Van Gompel, P., Wouters, R., & Lesage, A. S. (1996). Alniditan, a new 5-HYdroxytryptamine1D agonist and migraine-abortive agent: Ligand-binding properties of human 5-hydroxytryptamine1Dα, human 5-Hydroxytryptamine1Dβ, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H. Molecular Pharmacology, 50(6), 1567–1580.
   PubMedGoogle Scholar
• Lipinski, C. A. (2005). Capter 11 filtering in drug discovery. Annual reports in computational chemistry (Vol. 1, pp. 155–168). Elsevier.
   Google Scholar
• Lipinski, C. A. (2016). Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Advanced Drug Delivery Reviews, 101, 34–41. https://doi.org/10.1016/j.addr.2016.04.029
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997). Advanced Drug Delivery Reviews, 46(1–3), 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews , 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Liu, R., Li, X., & Lam, K. S. (2017). Combinatorial chemistry in drug discovery. Current Opinion in Chemical Biology, 38, 117–126. https://doi.org/10.1016/j.cbpa.2017.03.017
   PubMed Web of Science ®Google Scholar
• Lovering, F., Bikker, J., & Humblet, C. (2009). Escape from flatland: Increasing saturation as an approach to improving clinical success. Journal of Medicinal Chemistry, 52(21), 6752–6756. https://doi.org/10.1021/jm901241e
   PubMed Web of Science ®Google Scholar
• MacKenzie, R. G., VanLeeuwen, D., Pugsley, T. A., Shih, Y. H., Demattos, S., Tang, L., Todd, R. D., & O'Malley, K. L. (1994). Characterization of the human dopamine D3 receptor expressed in transfected cell lines. European Journal of Pharmacology, 266(1), 79–85. https://doi.org/10.1016/0922-4106(94)90212-7
   PubMed Web of Science ®Google Scholar
• McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophrenia—An overview. JAMA Psychiatry, 77(2), 201–210. https://doi.org/10.1001/jamapsychiatry.2019.3360
   PubMed Web of Science ®Google Scholar
• McGowan, O. O., & Reynolds, G. P. (2020). Functional pharmacogenetics of serotonin receptors in psychiatric drug action. Handbook of behavioral neuroscience (Vol. 31, pp. 941–957). Elsevier.
   Google Scholar
• Mierau, J., Schneider, F. J., Ensinger, H. A., Chio, C. L., Lajiness, M. E., & Huff, R. M. (1995). Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. European Journal of Pharmacology, 290(1), 29–36. https://doi.org/10.1016/0922-4106(95)90013-6
   PubMed Web of Science ®Google Scholar
• Millan, M. J., Brocco, M., Gobert, A., Schreiber, R., & Dekeyne, A. (1999). S-16924 [(R)-2-{1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)ethyl]- pyrrolidin-3yl}-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin(1A) agonist properties: III. Anxiolytic actions in comparison with clozapine and halope. Journal of Pharmacology and Experimental Therapeutics. 288, 1002–1014.
   PubMed Web of Science ®Google Scholar
• Millan, M. J., Peglion, J. L., Vian, J., Rivet, J. M., Brocco, M., Gobert, A., Newman- Tancredi, A., Dacquet, C., Bervoets, K., & Girardon, S. (1995). Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: I. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin. Journal of Pharmacology and Experimental Therapeutics. 275, 885–898.
   PubMed Web of Science ®Google Scholar
• Mok, N. Y., Maxe, S., & Brenk, R. (2013). Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. Journal of Chemical Information and Modeling, 53(3), 534–544. https://doi.org/10.1021/ci300382f
   PubMed Web of Science ®Google Scholar
• Moons, T., De Roo, M., Claes, S., & Dom, G. (2011). Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics, 12(8), 1193–1211. https://doi.org/10.2217/pgs.11.55
   PubMed Web of Science ®Google Scholar
• Moreno-Küstner, B., Martín, C., & Pastor, L. (2018). Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PloS One, 13(4), e0195687. https://doi.org/10.1371/journal.pone.0195687
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Muehlbacher, M., Spitzer, G. M., Liedl, K. R., & Kornhuber, J. (2011). Qualitative prediction of blood-brain barrier permeability on a large and refined dataset. Journal of Computer-Aided Molecular Design, 25(12), 1095–1106. https://doi.org/10.1007/s10822-011-9478-1
   PubMed Web of Science ®Google Scholar
• Mwesiga, E. K., Nakasujja, N., Muhwezi, W. W., & Musisi, S. (2021). The COVID-19 pandemic has reinforced the need for community mental health-care models in Uganda. The Lancet. Psychiatry, 8(5), 362. https://doi.org/10.1016/S2215-0366(21)00070-5
   PubMed Web of Science ®Google Scholar
• Mwesiga, E. K., Nakasujja, N., Nakku, J., Nanyonga, A., Gumikiriza, J. L., Bangirana, P., Akena, D., & Musisi, S. (2020). One year prevalence of psychotic disorders among first treatment contact patients at the National Psychiatric Referral and Teaching Hospital in Uganda. PloS One, 15(1), e0218843. https://doi.org/10.1371/journal.pone.0218843
   PubMed Web of Science ®Google Scholar
• Oka, T., Kubo, T., Kobayashi, N., Nakai, F., Miyake, Y., Hamamura, T., Honjo, M., Toda, H., Boku, S., Kanazawa, T., et al. (2021). Multiple time measurements of multidimensional psychiatric states from immediately before the COVID-19 pandemic to one year later: A longitudinal online survey of the Japanese population. Translational Psychiatry,.11, 1–8. https://doi.org/10.1038/s41398-021-01696-x
   PubMed Web of Science ®Google Scholar
• Oprea, T. I. (2000). Property distribution of drug-related chemical databases. Journal of Computer-Aided Molecular Design, 14(3), 251–264. https://doi.org/10.1023/A:1008130001697
   PubMed Web of Science ®Google Scholar
• Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001). Is there a difference between leads and drugs? A historical perspective. Journal of Chemical Information and Computer Sciences, 41(5), 1308–1315. https://doi.org/10.1021/ci010366a
   PubMedGoogle Scholar
• Pence, A. Y., Pries, L.-K., Ferrara, M., Rutten, B. P. F., van Os, J., & Guloksuz, S. (2022). Gender differences in the association between environment and psychosis. Schizophrenia Research, 243, 120–137. https://doi.org/10.1016/j.schres.2022.02.039
   PubMed Web of Science ®Google Scholar
• Pihan, E., Colliandre, L., Guichou, J.-F., & Douguet, D. (2012). e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics (Oxford, England), 28(11), 1540–1541. https://doi.org/10.1093/bioinformatics/bts186
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Platts, J. A., Abraham, M. H., Zhao, Y. H., Hersey, A., Ijaz, L., & Butina, D. (2001). Correlation and prediction of a large blood-brain distribution data set—An LFER study. European Journal of Medicinal Chemistry, 36(9), 719–730. https://doi.org/10.1016/s0223-5234(01)01269-7
   PubMed Web of Science ®Google Scholar
• Polito, N. B., & Fellows, S. E. (2017). Pharmacologic interventions for intractable and persistent hiccups: A systematic review. The Journal of Emergency Medicine, 53(4), 540–549. https://doi.org/10.1016/j.jemermed.2017.05.033
   PubMed Web of Science ®Google Scholar
• Potashman, M. H., & Duggan, M. E. (2009). Covalent modifiers: An orthogonal approach to drug design. Journal of Medicinal Chemistry, 52(5), 1231–1246. https://doi.org/10.1021/jm8008597
   PubMed Web of Science ®Google Scholar
• Przybylak, K. R., Alzahrani, A. R., & Cronin, M. T. D. (2014). How does the quality of phospholipidosis data influence the predictivity of structural alerts? Journal of Chemical Information and Modeling, 54(8), 2224–2232. https://doi.org/10.1021/ci500233k
   PubMed Web of Science ®Google Scholar
• Reynès, C., Host, H., Camproux, A.-C., Laconde, G., Leroux, F., Mazars, A., Deprez, B., Fahraeus, R., Villoutreix, B. O., & Sperandio, O. (2010). Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods. PLoS Computational Biology, 6(3), e1000695. https://doi.org/10.1371/journal.pcbi.1000695
   PubMed Web of Science ®Google Scholar
• Rishton, G. M. (2003). Nonleadlikeness and leadlikeness in biochemical screening. Drug Discovery Today, 8(2), 86–96. https://doi.org/10.1016/S1359644602025722
   PubMed Web of Science ®Google Scholar
• Rishton, G. M., LaBonte, K., Williams, A. J., Kassam, K., & Kolovanov, E. (2006). Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer’s disease. Current Opinion in Drug Discovery & Development, 9, 303–313.
   PubMed Web of Science ®Google Scholar
• Roberts, D. W., & Natsch, A. (2009). High throughput kinetic profiling approach for covalent binding to peptides: Application to skin sensitization potency of Michael acceptor electrophiles. Chemical Research in Toxicology, 22(3), 592–603. https://doi.org/10.1021/tx800431x
   PubMed Web of Science ®Google Scholar
• Roffman, J. L., & Pirl, W. F. (2003). Use of antipsychotic medicationin chemotherapy-induced nausea and vomiting. Expert Review of Neurotherapeutics, 3(1), 77–84. https://doi.org/10.1586/14737175.3.1.77
   PubMedGoogle Scholar
• Roper, C., & Tanguay, R. L. (2020). Tox21 and adverse outcome pathways. An introduction to interdisciplinary toxicology (pp. 559–568). Academic Press.
   Google Scholar
• Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004). Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia. Nature Reviews. Drug Discovery, 3(4), 353–359. https://doi.org/10.1038/nrd1346
   PubMed Web of Science ®Google Scholar
• Ryckaert, J. P., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics. 23(3), 327–341. https://doi.org/10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2013). An overview of the Amber biomolecular simulation package. Wiley Interdisciplinary Reviews: Computational Molecular Science, 3(2), 198–210. https://doi.org/10.1002/wcms.1121
   Web of Science ®Google Scholar
• Saudemont, G., Prod’Homme, C., Da Silva, A., Villet, S., Reich, M., Penel, N., & Gamblin, V. (2020). The use of olanzapine as an antiemetic in palliative medicine: A systematic review of the literature. BMC Palliative Care, 19, 1–11. https://doi.org/10.1186/S12904-020-00559-4/TABLES/2
   PubMed Web of Science ®Google Scholar
• Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996). Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology, 124(1-2), 57–73. https://doi.org/10.1007/BF02245606
   PubMed Web of Science ®Google Scholar
• Schüller, A., Schneider, G., & Byvatov, E. (2003). SMILIB: Rapid assembly of combinatorial libraries in SMILES notation. QSAR & Combinatorial Science, 22, 719–721. https://doi.org/10.1002/qsar.200310008
   Google Scholar
• Seale, C., Chaplin, R., Lelliott, P., & Quirk, A. (2007). Antipsychotic medication, sedation and mental clouding: An observational study of psychiatric consultations. Social Science & Medicine (1982), 65(4), 698–711. https://doi.org/10.1016/j.socscimed.2007.03.047
   PubMed Web of Science ®Google Scholar
• Seeman, P., Guan, H. ‐C., Van Tol, H. H. M., & Niznik, H. B. (1993). Low density of dopamine D4 receptors in Parkinson’s, schizophrenia, and control brain striata. Synapse (New York, N.Y.), 14(4), 247–253. https://doi.org/10.1002/syn.890140402
   PubMed Web of Science ®Google Scholar
• Sekhar, G. N., Fleckney, A. L., Boyanova, S. T., Rupawala, H., Lo, R., Wang, H., Farag, D. B., Rahman, K. M., Broadstock, M., Reeves, S., & Thomas, S. A. (2019). Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease. Fluids and Barriers of the CNS, 16(1), 38. https://doi.org/10.1186/s12987-019-0158-1
   PubMed Web of Science ®Google Scholar
• Shahid, M., Walker, G. B., Zorn, S. H., & Wong, E. H. F. (2009). Asenapine: A novel psychopharmacologic agent with a unique human receptor signature. Journal of Psychopharmacology (Oxford, England), 23(1), 65–73. https://doi.org/10.1177/0269881107082944
   PubMed Web of Science ®Google Scholar
• Shen, J., Cheng, F., Xu, Y., Li, W., & Tang, Y. (2010). Estimation of ADME properties with substructure pattern recognition. Journal of Chemical Information and Modeling, 50(6), 1034–1041. https://doi.org/10.1021/ci100104j
   PubMed Web of Science ®Google Scholar
• Shityakov, S., & Förster, C. (2014). In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter. Advances and Applications in Bioinformatics and Chemistry : AABC, 7, 23–36. https://doi.org/10.2147/AABC.S63749
   PubMedGoogle Scholar
• Shityakov, S., Salvador, E., Pastorin, G., & Förster, C. (2015). Blood-brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate. International Journal of Nanomedicine, 10, 1703–1713. https://doi.org/10.2147/IJN.S68429
   PubMed Web of Science ®Google Scholar
• Simons, P., Cosgrove, L., Shaughnessy, A. F., & Bursztajn, H. (2017). Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelines. International Journal of Law and Psychiatry, 55, 64–71. https://doi.org/10.1016/j.ijlp.2017.10.003
   PubMed Web of Science ®Google Scholar
• Singh, N., Guha, R., Giulianotti, M. A., Pinilla, C., Houghten, R. A., & Medina-Franco, J. L. (2009). Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. Journal of Chemical Information and Modeling, 49(4), 1010–1024. https://doi.org/10.1021/ci800426u
   PubMed Web of Science ®Google Scholar
• Sivakumar, K. C., Haixiao, J., Naman, C. B., & Sajeevan, T. P. (2020). Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process. Drug Development Research, 81(6), 685–699. https://doi.org/10.1002/ddr.21673
   PubMed Web of Science ®Google Scholar
• Smith, G. F. (2011). Designing drugs to avoid toxicity. Progress in Medicinal Chemistry, 50, 1–47. https://doi.org/10.1016/B978-0-12-381290-2.00001-X
   PubMedGoogle Scholar
• Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M. P., Giros, B., & Schwartz, J. C. (1992). Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: Comparison with D2 receptor. European Journal of Pharmacology, 225(4), 331–337. https://doi.org/10.1016/0922-4106(92)90107-7
   PubMed Web of Science ®Google Scholar
• Sperandio, O., Reynès, C. H., Camproux, A.-C., & Villoutreix, B. O. (2010). Rationalizing the chemical space of protein-protein interaction inhibitors. Drug Discovery Today, 15(5–6), 220–229. https://doi.org/10.1016/j.drudis.2009.11.007
   PubMed Web of Science ®Google Scholar
• Stepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011). Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chemical Research in Toxicology, 24(9), 1345–1410. https://doi.org/10.1021/tx200168d
   PubMed Web of Science ®Google Scholar
• Stroup, T. S., & Gray, N. (2018). Management of common adverse effects of antipsychotic medications. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 17(3), 341–356. https://doi.org/10.1002/wps.20567
   PubMed Web of Science ®Google Scholar
• Subramaniam, M., Abdin, E., Vaingankar, J. A., Sambasivam, R., Zhang, Y. J., Shafie, S., Basu, S., Chan, C. T., Tan, C. S., Verma, S. K., et al. (2021). Lifetime prevalence and correlates of schizophrenia and other psychotic disorders in Singapore. Frontiers in Psychiatry,.12, 249. https://doi.org/10.3389/fpsyt.2021.650674
   Web of Science ®Google Scholar
• Suenderhauf, C., Hammann, F., & Huwyler, J. (2012). Computational prediction of blood-brain barrier permeability using decision tree induction. Molecules, 17(9), 10429–10445. https://doi.org/10.3390/molecules170910429
   PubMed Web of Science ®Google Scholar
• Tamaian, R., Niculescu, V. C., & Anghel, M. (2010). In silico predictions for improving permeability properties of principal anticancer anthracyclines through structural modification. Bulletin of University of Agricultural Sciences and Veterinary Medicine, 67, 329–336.
   Google Scholar
• Tang, L., Todd, R. D., Heller, A., & O’Malley, K. L. (1994). Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. Journal of Pharmacology and Experimental Therapeutics, 268, 495–502.
   PubMed Web of Science ®Google Scholar
• Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021). Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet. Psychiatry, 8(2), 130–140. https://doi.org/10.1016/S2215-0366(20)30462-4
   PubMed Web of Science ®Google Scholar
• Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2017). Combining molecular scaffolds from FDA approved drugs: Application to drug discovery. Journal of Medicinal Chemistry, 60(5), 1638–1647. https://doi.org/10.1021/acs.jmedchem.6b01367
   PubMed Web of Science ®Google Scholar
• Thanontip, K., Chetsawang, B., & Chumchua, V. (2019). Novel protein-protein interaction network of antipsychotic drugs and cognitive function. Proceedings of the BMEiCON 2019 - 12th Biomedical Engineering International Conference; Institute of Electrical and Electronics Engineers Inc.
   Google Scholar
• Thomsen, R., & Christensen, M. H. (2006). MolDock: A new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry, 49(11), 3315–3321. https://doi.org/10.1021/jm051197e
   PubMed Web of Science ®Google Scholar
• Tice, M. A. B., Hashemi, T., Taylor, L. A., Duffy, R. A., & McQuade, R. D. (1994). Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Pharmacology, Biochemistry, and Behavior, 49(3), 567–571. https://doi.org/10.1016/0091-3057(94)90070-1
   PubMed Web of Science ®Google Scholar
• Todeschini, R., & Consonni, V. (2008). In R. Mannhold, H. Kubinyi, H. Timmerman (Eds.), Handbook of Molecular Descriptors. WILEY-VCH Verlag GmbH. ISBN 9783527613106.
   Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Vanover, K. E., Harvey, S. C., Son, T., Bradley, S. R., Kold, H., Makhay, M., Veinbergs, I., Spalding, T. A., Weiner, D. M., Andersson, C. M., Tolf, B.-R., Brann, M. R., Hacksell, U., & Davis, R. E. (2004). Pharmacological characterization of AC-90179 [2-(4-methoxy-phenyl)-N-(4- methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: A selective serotonin 2A receptor inverse agonist. The Journal of Pharmacology and Experimental Therapeutics, 310(3), 943–951. https://doi.org/10.1124/jpet.104.066688
   PubMed Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., Shoichet, B. K., Dror, R. O., & Roth, B. L. (2017). Crystal structure of an LSD-bound human serotonin receptor. Cell, 168(3), 377–389.e12. https://doi.org/10.1016/j.cell.2016.12.033
   PubMed Web of Science ®Google Scholar
• Wang, S., Che, T., Levit, A., Shoichet, B. K., Wacker, D., & Roth, B. L. (2018). Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature, 555(7695), 269–273. https://doi.org/10.1038/nature25758
   PubMed Web of Science ®Google Scholar
• Wang, Z., Chen, Y., Liang, H., Bender, A., Glen, R. C., & Yan, A. (2011). P-glycoprotein substrate models using support vector machines based on a comprehensive data set. Journal of Chemical Information and Modeling, 51(6), 1447–1456. https://doi.org/10.1021/ci2001583
   PubMed Web of Science ®Google Scholar
• Wang, S.-M., Han, C., Lee, S.-J., Jun, T.-Y., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2016). Second generation antipsychotics in the treatment of major depressive disorder: An update. Chonnam Medical Journal, 52(3), 159–172. https://doi.org/10.4068/CMJ.2016.52.3.159
   PubMedGoogle Scholar
• Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., McCorvy, J. D., Gao, X., Zhou, X. E., Melcher, K., Zhang, C., Bai, F., Yang, H., Yang, L., Jiang, H., … Xu, H. E. (2013). Structural basis for molecular recognition at serotonin receptors. Science (New York, N.Y.), 340(6132), 610–614. https://doi.org/10.1126/science.1232807
   PubMed Web of Science ®Google Scholar
• Wang, P., & Si, T. (2013). Use of antipsychotics in the treatment of depressive disorders. Shanghai Archives of Psychiatry, 25(3), 134–140. https://doi.org/10.3969/j.issn.1002-0829.2013.03.002
   PubMedGoogle Scholar
• Wang, S., Wacker, D., Levit, A., Che, T., Betz, R. M., McCorvy, J. D., Venkatakrishnan, A. J., Huang, X.-P., Dror, R. O., Shoichet, B. K., & Roth, B. L. (2017). D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science (New York, N.Y.), 358(6361), 381–386. https://doi.org/10.1126/science.aan5468
   PubMed Web of Science ®Google Scholar
• Wang, B., Zartaloudi, E., Linden, J. F., & Bramon, E. (2022). Neurophysiology in psychosis: The quest for disease biomarkers. Translational Psychiatry, 12(1), 10. https://doi.org/10.1038/s41398-022-01860-x
   PubMed Web of Science ®Google Scholar
• Weininger, D. (1988). SMILES, a chemical language and information system: 1: Introduction to methodology and encoding rules. Journal of Chemical Information and Computer Science, 28, 31–36. https://doi.org/10.1021/ci00057a005
   Google Scholar
• Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X. E., Cheng, X., Simon, I. A., Shen, D.-D., Yen, H.-Y., Robinson, C. V., Harpsøe, K., Svensson, B., Guo, J., Jiang, H., Gloriam, D. E., Melcher, K., Jiang, Y., Zhang, Y., & Xu, H. E. (2021). Structural insights into the lipid and ligand regulation of serotonin receptors. Nature, 592(7854), 469–473. https://doi.org/10.1038/s41586-021-03376-8
   PubMed Web of Science ®Google Scholar
• Yan, A., Liang, H., Chong, Y., Nie, X., & Yu, C. (2013). In-silico prediction of blood-brain barrier permeability. SAR and QSAR in Environmental Research, 24(1), 61–74. https://doi.org/10.1080/1062936X.2012.729224
   PubMed Web of Science ®Google Scholar
• Yang, F., Ma, Q., Ma, B., Jing, W., Liu, J., Guo, M., Li, J., Wang, Z., & Liu, M. (2021). Dyslipidemia prevalence and trends among adult mental disorder inpatients in Beijing, 2005–2018: A longitudinal observational study. Asian Journal of Psychiatry, 57, 102583. https://doi.org/10.1016/j.ajp.2021.102583
   PubMed Web of Science ®Google Scholar
• Zhang, W., Pei, J., & Lai, L. (2017). Computational multitarget drug design. Journal of Chemical Information and Modeling, 57(3), 403–412. https://doi.org/10.1021/acs.jcim.6b00491
   PubMed Web of Science ®Google Scholar